Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MDLN vs GSK✓SelectedUSD · GSKMDLN vs GSK performance historyLatest closeAs of+3.93%11/18
Stock and ETF performance explorer

MDLN vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-4.5%
GSK return
+2.0%
Excess return
-6.4%
Maximum drawdown
-36.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+3.9%-1.3%+5.3%+4.7%
7D-7.1%-3.1%-4.0%-5.5%
30D+11.3%-0.9%+12.2%+11.8%
3M+14.8%-4.2%+18.9%+17.1%
6M+8.7%-1.6%+10.3%+9.5%
YTD-6.8%+2.6%-9.4%-7.3%
All-4.5%+2.0%-6.4%-5.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling